LCN2 and chronic kidney disease: Compared to healthy controls, CKDu and CKD patients showed elevated median levels of several biomarkers including α1-microglobulin, β2-microglobulin, cystatin C, and retinol binding protein 4 (RBP4) and NGAL in varying degrees.